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Cheryl McQuire1, Angela Hassiotis2*, Bronwyn Harrison1 and Stephen Pilling3After the publication of the original article [1] in BMC
Psychiatry it was brought to our attention that Figs. 3, 4,
5, 6, 7, 8 and 9 were ordered incorrectly. Please find the
correct order of the figures and citations below.
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Fig. 4 The effect of aripiprazole and risperidone on weight and prolactin levels in children with intellectual disabilities and challenging behaviour
Fig. 3 The effect of risperidone and aripiprazole on challenging behaviour in children with intellectual disabilities
Fig. 5 The effect of aripiprazole and risperidone on sedation in children with intellectual disabilities and challenging behaviour
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Fig. 6 The effect of valproate and topiramate (added to risperidone) on challenging behaviour in children with intellectual disabilities
Fig. 7 The effect of valproate and topiramate (added to risperidone) on weight in children with intellectual disabilities and challenging behaviour
Fig. 8 The effect of valproate and topiramate (added to risperidone) on sedation in children with intellectual disabilities and challenging behaviour
Fig. 9 The effect of N-acetylcysteine on challenging behaviour in children with intellectual disabilities
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